Dr. Roy Ambinder, M. D.
What this data tells you about Dr. Ambinder
Dr. Roy Ambinder is a hematology (pathology) physician in Altamonte Springs, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ambinder performed 149,345 Medicare services across 4,102 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ambinder received a total of $1,082 from 24 pharmaceutical and/or device companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology (pathology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ambinder is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 43,860 | $0 | $4 |
| Iron sucrose injection (Venofer) | 30,400 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 20,000 | $43 | $137 |
| Immune globulin infusion (Gammagard) | 11,458 | $36 | $108 |
| Epoetin alfa injection (Procrit) for anemia | 10,980 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 8,580 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 6,240 | $1 | $5 |
| Complete blood count (CBC) with differential | 3,231 | $8 | $29 |
| Blood draw (venipuncture) | 3,095 | $8 | $9 |
| Dexamethasone injection (steroid) | 2,298 | $0 | $3 |
| Drug injection, under skin or into muscle | 1,782 | $10 | $69 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 1,012 | $1 | $6 |
| Office visit, established patient (30-39 min) | 990 | $95 | $339 |
| Office visit, established patient (20-29 min) | 947 | $64 | $239 |
| Anti-nausea injection (Aloxi/palonosetron) | 810 | $1 | $28 |
| Injection of additional new drug or substance into vein | 550 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 504 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 499 | $46 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 235 | $15 | $56 |
| Injection, diphenhydramine hcl, up to 50 mg | 227 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 192 | $21 | $79 |
| Injection, zoledronic acid, 1 mg | 180 | $6 | $69 |
| Office visit, established patient, complex (40-54 min) | 153 | $137 | $474 |
| Prothrombin time test (blood clotting) | 151 | $4 | $15 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 150 | $21 | $83 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 132 | $3 | $11 |
| Infusion into a vein for hydration, each additional hour | 90 | $10 | $42 |
| Administration of additional new drug or substance into vein, 1 hour or less | 72 | $48 | $178 |
| Infusion, normal saline solution , 1000 cc | 70 | $2 | $7 |
| Injection of drug or substance into vein | 68 | $28 | $156 |
| Infusion into a vein for hydration, 31-60 minutes | 62 | $25 | $156 |
| Red blood count automated, with additional calculations | 52 | $5 | $20 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 49 | $26 | $89 |
| New patient office visit (45-59 min) | 49 | $128 | $453 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 45 | $17 | $59 |
| Hospital follow-up visit, high complexity | 43 | $94 | $285 |
| Initial hospital admission, high complexity | 28 | $137 | $556 |
| Drawing of blood for a medical problem | 26 | $59 | $277 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 18 | $132 | $467 |
| New patient office visit, complex (60-74 min) | 17 | $168 | $585 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ambinder is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ambinder experienced with iron infusion (feraheme)?
Does Dr. Ambinder receive payments from pharmaceutical companies?
How do Dr. Ambinder's costs compare to other hematology (pathology) physicians in Altamonte Springs?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology